Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat.
Boughton-Smith
N K
NK
Department of Pharmacology, Research and Development Laboratories, Loughborough, Leicester, UK.
Ghelani
A
A
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004926:Escherichia coli / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism; D008297:Male; D019331:NG-Nitroarginine Methyl Ester; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D010538:Peritonitis / Q000139:chemically induced / Q000201:enzymology* / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D015054:Zymosan
D004791:Enzyme Inhibitors; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D003907:Dexamethasone; D015054:Zymosan; D001120:Arginine; D019001:Nitric Oxide Synthase; D003078:Colchicine; D019331:NG-Nitroarginine Methyl Ester